Advanced search
Publication Cover
Clinical Ophthalmology Volume 11, 2017 - Issue
Submit an article Journal homepage
55
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Treatment of myopic choroidal neovascularization with intravitreal ranibizumab injections: the role of age

Dimitrios Karagiannis1 Ophthalmiatreio Eye Hospital of Athens, Athens, Greece
,
Georgios A Kontadakis1 Ophthalmiatreio Eye Hospital of Athens, Athens, Greece;2 Department of Ophthalmology, University Hospital of Heraklion, University of Crete, Heraklio, GreeceCorrespondence[email protected]
,
Konstantinos Kaprinis1 Ophthalmiatreio Eye Hospital of Athens, Athens, Greece
,
Athanassios Giarmoukakis2 Department of Ophthalmology, University Hospital of Heraklion, University of Crete, Heraklio, Greece
,
Ilias Georgalas3 Department of Ophthalmology, University of Athens, Athens, Greece
,
Efstratios A Parikakis1 Ophthalmiatreio Eye Hospital of Athens, Athens, Greece
&
Miltiadis K Tsilimbaris2 Department of Ophthalmology, University Hospital of Heraklion, University of Crete, Heraklio, Greece
 show all
Pages 1197-1201 | Published online: 22 Jun 2017

References

  • WongTYFerreiraAHughesRCarterGMitchellPEpidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic reviewAm J Ophthalmol20141579.e1225.e1224099276
  • WongTYOhno-MatsuiKLevezielNMyopic choroidal neovascularisation: current concepts and update on clinical managementBritish J Ophthalmol201599289296
  • Ohno-MatsuiKLaiTYLaiCCCheungCMUpdates of pathologic myopiaProg Retin Eye Res20165215618726769165
  • Ohno-MatsuiKKawasakiRJonasJBMETA-analysis for Pathologic Myopia (META-PM) Study GroupInternational photographic classifi-cation and grading system for myopic maculopathyAm J Ophthalmol2015159877.e7883.e725634530
  • Ohno-MatsuiKYoshidaTFutagamiSPatchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopiaBr J Ophthalmol20038757057312714395
  • IaconoPBattaglia ParodiMPapayannisAFluorescein angiography and spectral-domain optical coherence tomography for monitoring anti-VEGF therapy in myopic choroidal neovascularizationOphthalmic Res201452253124861045
  • ChanNSTeoKCheungCMEpidemiology and diagnosis of myopic choroidal neovascularization in AsiaEye Contact Lens201642485526448447
  • CohenSYLarocheALeguenYSoubraneGCoscasGJEtiology of choroidal neovascularization in young patientsOphthalmology1996103124112448764794
  • YoshidaTOhno-MatsuiKYasuzumiKMyopic choroidal neovascularization: a 10-year follow-upOphthalmology20031101297130512867382
  • Axer-SiegelREhrlichRWeinbergerDPhotodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatmentAm J Ophthalmol200413860260715488787
  • MunkMRRückertRZinkernagelMEbneterAWolfSThe role of anti-VEGF agents in myopic choroidal neovascularization: current standards and future outlookExpert Opin Biol Ther201612111
  • YangHSKimJGKimJTJoeSGPrognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumabAm J Ophthalmol20131561201.e121210.e224075429
  • NgDSKwokAKTongJMChanCWLiWWFactors influencing need for retreatment and long-term visual outcome after intravitreal bevacizumab for myopic choroidal neovascularizationRetina2015352457246826035400
  • YoshidaTOhno-MatsuiKOhtakeYLong-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groupsOphthalmology200210971271911927428

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.